- Home
- NEWT vs RNAC Comparison
NEWT vs RNAC Comparison
Compare NEWT & RNAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NEWT
- RNAC
- Stock Information
- Founded
- NEWT 1998
- RNAC 2007
- Country
- NEWT United States
- RNAC United States
- Employees
- NEWT N/A
- RNAC N/A
- Industry
- NEWT Major Banks
- RNAC Biotechnology: Pharmaceutical Preparations
- Sector
- NEWT Finance
- RNAC Health Care
- Exchange
- NEWT Nasdaq
- RNAC Nasdaq
- Market Cap
- NEWT 294.8M
- RNAC 276.3M
- IPO Year
- NEWT N/A
- RNAC 2016
- Fundamental
- Price
- NEWT $12.37
- RNAC $10.05
- Analyst Decision
- NEWT Hold
- RNAC Strong Buy
- Analyst Count
- NEWT 4
- RNAC 4
- Target Price
- NEWT $13.00
- RNAC $40.00
- AVG Volume (30 Days)
- NEWT 188.9K
- RNAC 48.4K
- Earning Date
- NEWT 07-28-2025
- RNAC 08-07-2025
- Dividend Yield
- NEWT 6.14%
- RNAC N/A
- EPS Growth
- NEWT 21.23
- RNAC N/A
- EPS
- NEWT 2.01
- RNAC N/A
- Revenue
- NEWT $364,004,000.00
- RNAC $1,026,000.00
- Revenue This Year
- NEWT N/A
- RNAC N/A
- Revenue Next Year
- NEWT $12.73
- RNAC N/A
- P/E Ratio
- NEWT $6.15
- RNAC N/A
- Revenue Growth
- NEWT 20.91
- RNAC N/A
- 52 Week Low
- NEWT $9.12
- RNAC $8.46
- 52 Week High
- NEWT $15.49
- RNAC $26.50
- Technical
- Relative Strength Index (RSI)
- NEWT 61.20
- RNAC 34.71
- Support Level
- NEWT $12.16
- RNAC $10.50
- Resistance Level
- NEWT $12.48
- RNAC $11.80
- Average True Range (ATR)
- NEWT 0.27
- RNAC 0.56
- MACD
- NEWT 0.02
- RNAC -0.11
- Stochastic Oscillator
- NEWT 73.00
- RNAC 0.45
About NEWT NewtekOne Inc.
NewtekOne Inc is a financial holding company engaged in providing financial solutions to its Client Base. It is an internally managed non-diversified closed-end management investment company. It has four reportable segments Banking, Alternative Lending, Technology, NSBF, and Payments.
About RNAC Cartesian Therapeutics Inc.
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. The company leverages its proprietary technology and manufacturing platform to introduce one or more mRNA molecules into cells to enhance their function.